جامعة المعرفة
المصدر المعتمد للمعلومات البحثية والمخرجات هو قاعدة بيانات سكوبس (Elsevier Scopus) مع تدقيق بيانات الباحثين من عمادة البحث العلمي.

Research outputs

المخرجات البحثية

مقالات ومراجعات وأوراق مؤتمرات وفصول كتب، مفهرسة برقم DOI ومربوطة بباحثي الجامعة.

12 مُخرَج نتائج البحث عن «Transdermal»

مراجعةوصول مغلق20252استشهاد· Semantic Scholar

Novel Drug Delivery Systems Approved by USFDA from 2019 to 2023: A Comprehensive Review

Current Drug Delivery · مجلد 23 (4) · 396-422

In recent years, tremendous progress in the field of novel drug delivery systems (NDDS), which has prompted the creation of new strategies to enhance treatment results and patient compliance. The goal of this comprehensive review is to provide a summary of the NDDS that the US Food and Drug Administration (USFDA) has approved from 2019 to 2023. Various databases, including PubMed, Scopus, USFDA, and patent websites were utilized to gather relevant information. The selected NDDSs were categorized based on their delivery route, such as oral, injectable, transdermal, pulmonary, nasal, ocular, and implantable. For each delivery route, the review provides a detailed analysis of the approved NDDSs, including their mechanisms of action, advantages, limitations, and clinical applications. Additionally, the review discusses the challenges faced during the development and commercialization of these systems, as well as the prospects and potential areas of improvement. The findings of this comprehensive review demonstrate the remarkable progress made in the field of NDDSs, with the USFDA approving several innovative technologies in recent years. The approved NDDSs have shown promising results in enhancing drug stability, bioavailability, and controlled release, leading to improved therapeutic outcomes and patient convenience. In conclusion, this comprehensive review provides a valuable resource for researchers, healthcare professionals, and pharmaceutical industries, offering insights into the latest advancements in NDDSs approved by the US FDA. The knowledge gained from this review can guide future research endeavors, foster innovation, and contribute to developing more effective and patient-friendly NDDS strategies.

novel drug delivery systemstransdermal drug deliverypulmonary drug deliveryintranasal drug delivery
مقالوصول مفتوح20251استشهاد· Semantic Scholar

Relevance of topical application of minoxidil laden nano-lipid for hair growth enhancement

Saudi Pharmaceutical Journal · مجلد 33 (6) · 47-47

Practically, all patients treated with Minoxidil (MXD) reported experiencing hypertrichosis, even though the original intended usage of the drug was the treatment of hypertension. This limitation supports the potential of repurposing MXD as a topical agent for the treatment of hair loss. Accordingly, the outset of the current study was to exploit the cutaneous influence of MXD and limit the drawbacks of conventional available dosage forms. This could be achieved via developing a nanocarrier, mainly; nanoemulsion (NE) for transdermal delivery of MXD. Therefore, several NEs were prepared containing MXD and optimized according to their particle size and in vitro release study using Response Surface Methodology. The optimized formulation was examined for its organoleptic properties, pH, viscosity, and drug content. Moreover, Morphology, kinetic study was investigated a long with the stability testing upon keeping in two distinct settings: room temperature and refrigerator for 12 months. Eventually, the in vivo hair growth rate was monitored and documented for 28 days in pretreated mice. The developed MXD-NEs were developed and optimized using Box Behnken Design software to obtain the most desired formula. The optimized MXD-NE demonstrated a nanosize (83.1 nm) and performs a successful in vitro release (75.6%) over a period of 6 h. Additionally, it showed ideal physical properties with pH (5.9), viscosity (26.7 cP), and drug content (99.4%). The droplets in the formula seemed to be spherical. The formula was stable when preserved for 12 months at both applied conditions. Finally, the formula demonstrated significant faster rate of hair growth that mostly owed to the value of nanocarrier in delivering drug into follicular hairs.

minoxidilnanoemulsionstopical drug deliveryhair growth
مقالمفتوح (مستودع)20251استشهاد· Semantic Scholar

Navigating the Neurological Frontier: A Comprehensive Review of Transdermal Drug Delivery Systems for Neurodegenerative Diseases

Advanced Health Science and Technology Journal · مجلد 1 (2) · 57-64

Abstract Neurodegenerative diseases pose a growing challenge to global health due to their chronic progression, limited treatment options, and significant impact on patient quality of life. Traditional drug delivery methods – primarily oral or injectable routes – are frequently hindered by systemic side effects, first-pass metabolism, poor blood–brain barrier penetration, and low patient adherence, particularly in elderly populations. In recent years, transdermal drug delivery systems (TDDS), particularly in the form of medicated patches, have gained traction as a noninvasive, sustained-release alternative for managing neurological conditions. These systems enable controlled systemic delivery, circumvent gastrointestinal degradation, and improve pharmacokinetic stability, making them particularly advantageous in neurodegenerative care. This review critically evaluates the use of transdermal patches, with a focus on current applications, mechanisms of transdermal absorption, and the pharmacological rationale for their use. It further explores emerging innovations in patch design – including nanoparticle-enhanced and smart patches – while also addressing key limitations such as drug physicochemical constraints and variability in skin permeability. Current evidence suggests that TDDS can enhance therapeutic outcomes and adherence, marking a significant step forward in patient-centric neurology. Continued advancements in material science and clinical trial integration are expected to further broaden their therapeutic scope in the coming decade.

transdermal drug deliverytransdermal patchneurodegenerative diseasesblood-brain barrier
مراجعةوصول مفتوح202423استشهاد· Semantic Scholar

An insight into pharmaceutical challenges with ionic liquids: where do we stand in transdermal delivery?

Frontiers in Bioengineering and Biotechnology · مجلد 12 · 1454247-1454247

Ionic liquids (ILs) represent an exciting and promising solution for advancing drug delivery platforms. Their unique properties, including broad chemical diversity, adaptable structures, and exceptional thermal stability, make them ideal candidates for overcoming challenges in transdermal drug delivery. Despite encountering obstacles such as side reactions, impurity effects, biocompatibility concerns, and stability issues, ILs offer substantial potential in enhancing drug solubility, navigating physiological barriers, and improving particle stability. To propel the use of IL-based drug delivery in pharmaceutical innovation, it is imperative to devise new strategies and solvents that can amplify drug effectiveness, facilitate drug delivery to cells at the molecular level, and ensure compatibility with the human body. This review introduces innovative methods to effectively address the challenges associated with transdermal drug delivery, presenting progressive approaches to significantly improve the efficacy of this drug delivery system.

ionic liquidstransdermal drug deliveryskin permeationdrug solubility enhancement
مقالوصول مفتوح2023

Effectiveness of Iontophoretic Application of Curcumin Extracts among Patients Suffering from Rheumatoid Arthritis

Indian Journal of Pharmaceutical Sciences · مجلد 85 (S2)

Curcumin has a powerful anti-inflammatory impact, despite its limited absorption when given orally. Earlier research has proved the efficacy of the curcumin extracts in the rat model and therefore the present study is an attempt to evaluate the effects of lyophilized curcumin extracts delivered through iontophoresis among patients suffering from rheumatoid arthritis. Lyophilized curcumin extracts having 29.79 % curcumin as its active ingredient was prepared using standardized method and it was applied to the inflamed hands of the rheumatoid arthritis patients, satisfying the inclusion criteria. Another group of patients were treated with oral curcumin. The prospective study was done among 20 patients at LifeLine Rehab Center who were diagnosed during January 2022 to August 2022. The experimental group use iontophoretically treated curcumin which showed significant improvement as compared to their matched controls. Iontophoretic application of lyophilized curcumin extracts has been found to provide a greater anti-arthritic impact due to improved curcumin penetration and bioavailability. Future studies can be conducted to examine the effects of different curcumin applications in arthritic conditions and examining their action pathways. english xxx, xxx videos hd videos, hindi xxx, xxx hindi video, indian sexy couple, sexy indian dancing girl nude

curcuminiontophoresisrheumatoid arthritistransdermal drug delivery
مقالوصول مفتوح202284استشهاد· Semantic Scholar

Surface-Modified Bilosomes Nanogel Bearing a Natural Plant Alkaloid for Safe Management of Rheumatoid Arthritis Inflammation

Pharmaceutics · مجلد 14 (3) · 563-563

Rheumatoid arthritis (RA) is a chronic inflammatory illness affecting the joints. The characteristic of RA is gradual joint deterioration. Current RA treatment alleviates signs such as inflammation and pain and substantially slows the progression of the disease. In this study, we aimed to boost the transdermal delivery of berberine (a natural product) by encapsulating it in chitosan, surface-modified bilosomes nanogel for better management of the inflammation of RA. The chitosan-coated bilosomes loaded with berberine (BER-CTS-BLS) were formulated according to the thin-film hydration approach and optimized for various causal variables, considering the effect of lipid, sodium deoxycholate, and chitosan concentrations on the size of the particles, entrapment, and the surface charge. The optimized BER-CTS-BLS has 202.3 nm mean diameter, 83.8% entrapment, and 30.8 mV surface charge. The optimized BER-CTS-BLS exhibited a delayed-release profile in vitro and increased skin permeability ex vivo. Additionally, histological examination revealed that the formulated BLS had no irritating effects on the skin. Furthermore, the optimized BER-CTS-BLS ability to reduce inflammation was evaluated in rats with carrageenan-induced paw edema. Our results demonstrate that the group treated with topical BER-CTS-BLS gel exhibited a dramatic reduction in rat paw edema swelling percentage to reach 24.4% after 12 h, which was substantially lower than other groups. Collectively, chitosan-coated bilosomes containing berberine have emerged as a promising therapeutic approach to control RA inflammation.

rheumatoid arthritisberberinebilosomeschitosan coating
مقالوصول مفتوح202274استشهاد· Semantic Scholar

Fabrication and Evaluation of Voriconazole Loaded Transethosomal Gel for Enhanced Antifungal and Antileishmanial Activity

Molecules · مجلد 27 (10) · 3347-3347

Voriconazole (VRC) is a broad-spectrum antifungal agent belonging to BCS class II (biopharmaceutical classification system). Despite many efforts to enhance its solubility, this primary issue still remains challenging for formulation scientists. Transethosomes (TELs) are one of the potential innovative nano-carriers for improving the solubility and permeation of poorly soluble and permeable drugs. We herein report voriconazole-loaded transethosomes (VRCT) fabricated by the cold method and followed by their incorporation into carbopol 940 as a gel. The prepared VRCT were evaluated for % yield, % entrapment efficiency (EE), surface morphology, possible chemical interaction, particle size, zeta potential, and polydispersity index (PDI). The optimized formulation had a particle size of 228.2 nm, a zeta potential of −26.5 mV, and a PDI of 0.45 with enhanced % EE. Rheology, spreadability, extrudability, in vitro release, skin permeation, molecular docking, antifungal, and antileishmanial activity were also assessed for VRCT and VRC loaded transethosomal gel (VTEG). Ex-vivo permeation using rat skin depicted a transdermal flux of 22.8 µg/cm2/h with enhanced efficiency up to 4-fold. A two-fold reduction in inhibitory as well as fungicidal concentration was observed against various fungal strains by VRCT and VTEG besides similar results against L-donovani. The development of transethosomal formulation can serve as an efficient drug delivery system through a topical route with enhanced efficacy and better patient compliance.

voriconazoletransethosomesantifungal activityantileishmanial activity
مقالوصول مفتوح202238استشهاد· Semantic Scholar

Formulation and Evaluation of Topical Nano-Lipid-Based Delivery of Butenafine: In Vitro Characterization and Antifungal Activity

Gels · مجلد 8 (2) · 133-133

The present research work was designed to prepare butenafine (BN)-loaded bilosomes (BSs) by the thin-film hydration method. BN is a sparingly water-soluble drug having low permeability and bioavailability. BSs are lipid-based nanovesicles used to entrap water-insoluble drugs for enhanced permeation across the skin. BSs were prepared by the thin-film hydration method and optimized by the Box–Behnken design (BBD) using lipid (A), span 60 (B), and sodium deoxycholate (C) as independent variables. The selected formulation (BN-BSo) was converted into the gel using Carbopol 940 as a gelling agent. The prepared optimized gel (BN-BS-og) was further evaluated for the gel characterization, drug release, drug permeation, irritation, and anti-fungal study. The optimized bilosomes (BN-BSo) showed a mean vesicle size of 215 ± 6.5 nm and an entrapment efficiency of 89.2 ± 1.5%. The DSC study showed that BN was completely encapsulated in the BS lipid matrix. BN-BSog showed good viscosity, consistency, spreadability, and pH. A significantly (p < 0.05) high release (81.09 ± 4.01%) was achieved from BN-BSo compared to BN-BSog (65.85 ± 4.87%) and pure BN (17.54 ± 1.37 %). The permeation study results revealed that BN-BSo, BN-BSog, and pure BN exhibited 56.2 ± 2.7%, 39.2 ± 2.9%, and 16.6 ± 2.3%. The enhancement ratio of permeation flux was found to be 1.4-fold and 3.4-fold for the BN-BS-og and pure BN dispersion. The HET-CAM study showed that BN-BSog was found to be nonirritant as the score was found within the limit. The antifungal study revealed a significant (p < 0.05) enhanced antifungal activity against C. albicans and A. niger. The findings of the study revealed that BS is an important drug delivery system for transdermal delivery.

butenafinebilosomestopical drug deliveryantifungal activity
مقالمفتوح (مستودع)202230استشهاد· Semantic Scholar

Polymeric ethosomal gel loaded with nimodipine: Optimisation, pharmacokinetic and histopathological analysis

Saudi Pharmaceutical Journal · مجلد 30 (11) · 1603-1611

This study was performed with the main objective of formulating and evaluating the potential of ethosomesl gel (Etho gel) to deliver nimodipine (NiM) for cardiovascular disease, a potent water insoluble anti-hypertensive drug via skin to reach the deeper layers of skin. The Box-Behnken design (BBD) was used to optimize the NiM-Eth to determine the impact of the independent and depended variables. The effectiveness of drug entrapment, vesicle size, and cumulative drug release were assessed for the NiM loaded ethosomes and NiM-Eth gel using carbopol 934 as a gelling agent. Fourier transform infrared spectroscopy (FTIR), Differential scanning calorimetry (DSC), Power X-ray diffraction (PXRD), and scanning electron microscopy (SEM) analysis were performed and analysed their physicochemical characters. Rat abdomen skin was used to investigate drug permeability and deposition. As compared to marketed products, NiM-Eth gel produced an improved drug permeability in ex vivo experiments. The mean AUC0 to AUC0-∞ of NiM-Eth gel when compared to oral formulation (Nymalize oral preparation) was found to be increased from 4.1 to 5.9 folds which was found to be resulted from first pass effect. Histophatlogical findings revealed that the maximum amount of NiM penetrated the stratum corneum of the skin and create drug depots in the deep layer. In summary, it can be said that NiM might be successfully prepared in NiM-Eth gel for transdermal drug delivery.

nimodipineethosomestransdermal drug deliverypolymer gels